UQCRC2 and Alzheimer disease: Moreover, APOE4 (1-272) fragment preferentially binds UQCRC2 to inhibit the enzymatic activity of complex III and promote the formation of neurofibrillary tangle-like structures, hence directly linking UQCRC2 to AD pathology [77].